{"id":870469,"date":"2025-08-04T19:29:12","date_gmt":"2025-08-04T23:29:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/"},"modified":"2025-08-04T19:29:12","modified_gmt":"2025-08-04T23:29:12","slug":"shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/","title":{"rendered":"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Aug. 4, 2025<\/span><\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4481217-5&amp;h=3405196137&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Frxsight-inc-nasdaq-rxst%2F&amp;a=Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/a>\u00a0announces that a securities class action lawsuit has been filed\u00a0on behalf of all persons or entities who purchased the securities of RxSight, Inc. (NASDAQ: RXST) (&#8220;RxSight&#8221; or the &#8220;Company&#8221;).<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\" title=\"(PRNewsfoto\/Wolf Haldenstein Adler Freeman )\" alt=\"(PRNewsfoto\/Wolf Haldenstein Adler Freeman )\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p class=\"prntac\">\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4481217-5&amp;h=3749054566&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Frxsight-inc-nasdaq-rxst%2F&amp;a=PLEASE+CLICK+HERE+TO+JOIN+THE+CASE+AND+SUBMIT+CONTACT+INFORMATION\" target=\"_blank\" rel=\"nofollow\"><br \/>\n          <b>PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION<\/b><br \/>\n        <\/a>\n      <\/p>\n<p>\n        <b>\u00a0RxSight, Inc. Class Action Lawsuit Summary<\/b>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <b>Defendant:<\/b>\u00a0RxSight, Inc. (NASDAQ: RXST)<\/p>\n<\/li>\n<li>\n          <b>Class Period:<\/b> Investors who purchased or otherwise acquired RxSight securities within the relevant period of <span class=\"xn-chron\">November 7, 2024<\/span> through <span class=\"xn-chron\">July 8, 2025<\/span>, inclusive, may be eligible.<\/p>\n<\/li>\n<li>\n          <b>Allegations:<\/b>\u00a0Securities <span>fraud<\/span> and\/or other unlawful business practices by RxSight and certain officers or directors.<\/p>\n<\/li>\n<li>\n          <b>Key Event:<\/p>\n<p><\/b>\n        <\/li>\n<ul type=\"circle\">\n<li>On <b><span class=\"xn-chron\">July 8, 2025<\/span><\/b>, RxSight reported <b>preliminary Q2 2025 results<\/b>, disclosing:\n<\/li>\n<ul type=\"square\">\n<li>Significant declines in sales of its Light Delivery Device (LDD)\n<\/li>\n<li>Lower usage of light adjustable intraocular lenses\n<\/li>\n<li>Overall revenue shortfall\n<\/li>\n<li>\n              <b>Full year 2025 guidance cut by approximately <span class=\"xn-money\">$42.5 million<\/span><\/b>\u00a0<\/p>\n<\/li>\n<\/ul>\n<li>CEO <b><span class=\"xn-person\">Ronald Kurtz<\/span><\/b> cited <i>&#8220;adoption challenges&#8221;<\/i> as a major factor for the sales stall.\n<\/li>\n<li>Following this news, the stock price dropped <b><span class=\"xn-money\">$4.84<\/span><\/b> (\u221237.84%) to <b><span class=\"xn-money\">$7.95<\/span><\/b> per share on <b><span class=\"xn-chron\">July 9, 2025<\/span><\/b>.<\/li>\n<\/ul>\n<li>\n          <b>Important Deadline:<\/b>\u00a0<b>Lead Plaintiff<\/b> deadline is <b><span class=\"xn-chron\">September 22, 2025<\/span><\/b>. Please contact <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4481217-5&amp;h=4064262608&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Frxsight-inc-nasdaq-rxst%2F&amp;a=Wolf+Haldenstein\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Wolf Haldenstein<\/span><\/a>\u00a0to learn more about your rights as a shareholder.<\/li>\n<\/ul>\n<p>\n        <b>Why\u00a0<\/b><br \/>\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4481217-5&amp;h=3405196137&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Frxsight-inc-nasdaq-rxst%2F&amp;a=Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP\" target=\"_blank\" rel=\"nofollow\"><br \/>\n          <b><br \/>\n            <span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/b><br \/>\n        <\/a><br \/>\n        <b>?<\/b><br \/>\n        <b>:<\/b>\n      <\/p>\n<p>This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements.\u00a0The law firm\u00a0brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.<\/p>\n<p>We encourage all investors who have been affected or have information that will assist in our investigation, to contact\u00a0Wolf Haldenstein Adler Freeman &amp; Herz LLP.<\/p>\n<p>\n        <b>Contact:<\/b>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <b>Phone:<\/b>\u00a0(800) 575-0735 or (212) 545-4774<\/li>\n<li>\n          <b>Email:\u00a0<\/b><br \/>\n          <a href=\"mailto:classmember@whafh.com\" target=\"_blank\" rel=\"nofollow\">classmember@whafh.com<\/a>\n        <\/li>\n<li>\n          <b>Contact Person:<\/b>\u00a0<a href=\"mailto:gstone@whafh.com\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Gregory Stone<\/span>, Director of Case and Financial Analysis<\/a><\/li>\n<\/ul>\n<p>\n        <b>Firm Website:<\/b>\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4481217-5&amp;h=3405196137&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Frxsight-inc-nasdaq-rxst%2F&amp;a=Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/a><\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY43784&amp;sd=2025-08-04\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-302521048.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-302521048.html<\/a><\/p>\n<p>SOURCE  <span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY43784&amp;Transmission_Id=202508041653PR_NEWS_USPR_____NY43784&amp;DateId=20250804\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , Aug. 4, 2025 \/PRNewswire\/ &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP\u00a0announces that a securities class action lawsuit has been filed\u00a0on behalf of all persons or entities who purchased the securities of RxSight, Inc. (NASDAQ: RXST) (&#8220;RxSight&#8221; or the &#8220;Company&#8221;). PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION \u00a0RxSight, Inc. Class Action Lawsuit Summary Defendant:\u00a0RxSight, Inc. (NASDAQ: RXST) Class Period: Investors who purchased or otherwise acquired RxSight securities within the relevant period of November 7, 2024 through July 8, 2025, inclusive, may be eligible. Allegations:\u00a0Securities fraud and\/or other unlawful business practices by RxSight and certain officers or directors. Key Event: On July 8, 2025, RxSight reported preliminary Q2 2025 results, disclosing: Significant &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-870469","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , Aug. 4, 2025 \/PRNewswire\/ &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP\u00a0announces that a securities class action lawsuit has been filed\u00a0on behalf of all persons or entities who purchased the securities of RxSight, Inc. (NASDAQ: RXST) (&#8220;RxSight&#8221; or the &#8220;Company&#8221;). PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION \u00a0RxSight, Inc. Class Action Lawsuit Summary Defendant:\u00a0RxSight, Inc. (NASDAQ: RXST) Class Period: Investors who purchased or otherwise acquired RxSight securities within the relevant period of November 7, 2024 through July 8, 2025, inclusive, may be eligible. Allegations:\u00a0Securities fraud and\/or other unlawful business practices by RxSight and certain officers or directors. Key Event: On July 8, 2025, RxSight reported preliminary Q2 2025 results, disclosing: Significant &hellip; Continue reading &quot;Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-04T23:29:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd\",\"datePublished\":\"2025-08-04T23:29:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\\\/\"},\"wordCount\":364,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\\\/\",\"name\":\"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"datePublished\":\"2025-08-04T23:29:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/","og_locale":"en_US","og_type":"article","og_title":"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - Market Newsdesk","og_description":"PR Newswire NEW YORK , Aug. 4, 2025 \/PRNewswire\/ &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP\u00a0announces that a securities class action lawsuit has been filed\u00a0on behalf of all persons or entities who purchased the securities of RxSight, Inc. (NASDAQ: RXST) (&#8220;RxSight&#8221; or the &#8220;Company&#8221;). PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION \u00a0RxSight, Inc. Class Action Lawsuit Summary Defendant:\u00a0RxSight, Inc. (NASDAQ: RXST) Class Period: Investors who purchased or otherwise acquired RxSight securities within the relevant period of November 7, 2024 through July 8, 2025, inclusive, may be eligible. Allegations:\u00a0Securities fraud and\/or other unlawful business practices by RxSight and certain officers or directors. Key Event: On July 8, 2025, RxSight reported preliminary Q2 2025 results, disclosing: Significant &hellip; Continue reading \"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-04T23:29:12+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd","datePublished":"2025-08-04T23:29:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/"},"wordCount":364,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/","name":"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","datePublished":"2025-08-04T23:29:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-their-rxsight-inc-nasdaq-rxst-investment-should-contact-wolf-haldenstein-immediately-as-the-lead-plaintiff-deadline-is-september-22nd-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/870469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=870469"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/870469\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=870469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=870469"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=870469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}